Global Newcastle Disease Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
According to APO Research, The global Newcastle Disease Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN and Zoetis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Newcastle Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Newcastle Disease Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Newcastle Disease Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Newcastle Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Newcastle Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Newcastle Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.
Newcastle Disease Vaccine segment by Company
1. To analyze and research the global Newcastle Disease Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Newcastle Disease Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Newcastle Disease Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Newcastle Disease Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Newcastle Disease Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Newcastle Disease Vaccine industry.
Chapter 3: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Newcastle Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Newcastle Disease Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
According to APO Research, The global Newcastle Disease Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Newcastle Disease Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, Yebio, Harbin Veterinary Research Institute, Merck Animal Health, DHN and Zoetis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Newcastle Disease Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Newcastle Disease Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Newcastle Disease Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Newcastle Disease Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Newcastle Disease Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Newcastle Disease Vaccine sales, projected growth trends, production technology, application and end-user industry.
Newcastle Disease Vaccine segment by Company
- Merial
- CEVA
- QYH Biotech
- Ringpu Biology
- Yebio
- Harbin Veterinary Research Institute
- Merck Animal Health
- DHN
- Zoetis
- ChengDu Tecbond
- Elanco (Lohmann)
- FATRO
- CAVAC
- Vaksindo
- Live Vaccines
- Killed Vaccines
- Chicken
- Duck & Goose
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Newcastle Disease Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Newcastle Disease Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Newcastle Disease Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Newcastle Disease Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Newcastle Disease Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Newcastle Disease Vaccine industry.
Chapter 3: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Newcastle Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Newcastle Disease Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Newcastle Disease Vaccine Sales Value (2019-2030)
1.2.2 Global Newcastle Disease Vaccine Sales Volume (2019-2030)
1.2.3 Global Newcastle Disease Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 NEWCASTLE DISEASE VACCINE MARKET DYNAMICS
2.1 Newcastle Disease Vaccine Industry Trends
2.2 Newcastle Disease Vaccine Industry Drivers
2.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
2.4 Newcastle Disease Vaccine Industry Restraints
3 NEWCASTLE DISEASE VACCINE MARKET BY COMPANY
3.1 Global Newcastle Disease Vaccine Company Revenue Ranking in 2023
3.2 Global Newcastle Disease Vaccine Revenue by Company (2019-2024)
3.3 Global Newcastle Disease Vaccine Sales Volume by Company (2019-2024)
3.4 Global Newcastle Disease Vaccine Average Price by Company (2019-2024)
3.5 Global Newcastle Disease Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Newcastle Disease Vaccine Company Manufacturing Base & Headquarters
3.7 Global Newcastle Disease Vaccine Company, Product Type & Application
3.8 Global Newcastle Disease Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Newcastle Disease Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Newcastle Disease Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 NEWCASTLE DISEASE VACCINE MARKET BY TYPE
4.1 Newcastle Disease Vaccine Type Introduction
4.1.1 Live Vaccines
4.1.2 Killed Vaccines
4.2 Global Newcastle Disease Vaccine Sales Volume by Type
4.2.1 Global Newcastle Disease Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Newcastle Disease Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Newcastle Disease Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Newcastle Disease Vaccine Sales Value by Type
4.3.1 Global Newcastle Disease Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Newcastle Disease Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Newcastle Disease Vaccine Sales Value Share by Type (2019-2030)
5 NEWCASTLE DISEASE VACCINE MARKET BY APPLICATION
5.1 Newcastle Disease Vaccine Application Introduction
5.1.1 Chicken
5.1.2 Duck & Goose
5.1.3 Other
5.2 Global Newcastle Disease Vaccine Sales Volume by Application
5.2.1 Global Newcastle Disease Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Newcastle Disease Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Newcastle Disease Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Newcastle Disease Vaccine Sales Value by Application
5.3.1 Global Newcastle Disease Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Newcastle Disease Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Newcastle Disease Vaccine Sales Value Share by Application (2019-2030)
6 NEWCASTLE DISEASE VACCINE MARKET BY REGION
6.1 Global Newcastle Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Newcastle Disease Vaccine Sales by Region (2019-2030)
6.2.1 Global Newcastle Disease Vaccine Sales by Region: 2019-2024
6.2.2 Global Newcastle Disease Vaccine Sales by Region (2025-2030)
6.3 Global Newcastle Disease Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Newcastle Disease Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Newcastle Disease Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Newcastle Disease Vaccine Sales Value by Region (2025-2030)
6.5 Global Newcastle Disease Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Newcastle Disease Vaccine Sales Value (2019-2030)
6.6.2 North America Newcastle Disease Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Newcastle Disease Vaccine Sales Value (2019-2030)
6.7.2 Europe Newcastle Disease Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Newcastle Disease Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Newcastle Disease Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Newcastle Disease Vaccine Sales Value (2019-2030)
6.9.2 Latin America Newcastle Disease Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Newcastle Disease Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Newcastle Disease Vaccine Sales Value Share by Country, 2023 VS 2030
7 NEWCASTLE DISEASE VACCINE MARKET BY COUNTRY
7.1 Global Newcastle Disease Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Newcastle Disease Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Newcastle Disease Vaccine Sales by Country (2019-2030)
7.3.1 Global Newcastle Disease Vaccine Sales by Country (2019-2024)
7.3.2 Global Newcastle Disease Vaccine Sales by Country (2025-2030)
7.4 Global Newcastle Disease Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Newcastle Disease Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Newcastle Disease Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Merial
8.1.1 Merial Comapny Information
8.1.2 Merial Business Overview
8.1.3 Merial Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Merial Newcastle Disease Vaccine Product Portfolio
8.1.5 Merial Recent Developments
8.2 CEVA
8.2.1 CEVA Comapny Information
8.2.2 CEVA Business Overview
8.2.3 CEVA Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
8.2.5 CEVA Recent Developments
8.3 QYH Biotech
8.3.1 QYH Biotech Comapny Information
8.3.2 QYH Biotech Business Overview
8.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
8.3.5 QYH Biotech Recent Developments
8.4 Ringpu Biology
8.4.1 Ringpu Biology Comapny Information
8.4.2 Ringpu Biology Business Overview
8.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
8.4.5 Ringpu Biology Recent Developments
8.5 Yebio
8.5.1 Yebio Comapny Information
8.5.2 Yebio Business Overview
8.5.3 Yebio Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
8.5.5 Yebio Recent Developments
8.6 Harbin Veterinary Research Institute
8.6.1 Harbin Veterinary Research Institute Comapny Information
8.6.2 Harbin Veterinary Research Institute Business Overview
8.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
8.6.5 Harbin Veterinary Research Institute Recent Developments
8.7 Merck Animal Health
8.7.1 Merck Animal Health Comapny Information
8.7.2 Merck Animal Health Business Overview
8.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
8.7.5 Merck Animal Health Recent Developments
8.8 DHN
8.8.1 DHN Comapny Information
8.8.2 DHN Business Overview
8.8.3 DHN Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.8.4 DHN Newcastle Disease Vaccine Product Portfolio
8.8.5 DHN Recent Developments
8.9 Zoetis
8.9.1 Zoetis Comapny Information
8.9.2 Zoetis Business Overview
8.9.3 Zoetis Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
8.9.5 Zoetis Recent Developments
8.10 ChengDu Tecbond
8.10.1 ChengDu Tecbond Comapny Information
8.10.2 ChengDu Tecbond Business Overview
8.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
8.10.5 ChengDu Tecbond Recent Developments
8.11 Elanco (Lohmann)
8.11.1 Elanco (Lohmann) Comapny Information
8.11.2 Elanco (Lohmann) Business Overview
8.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
8.11.5 Elanco (Lohmann) Recent Developments
8.12 FATRO
8.12.1 FATRO Comapny Information
8.12.2 FATRO Business Overview
8.12.3 FATRO Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
8.12.5 FATRO Recent Developments
8.13 CAVAC
8.13.1 CAVAC Comapny Information
8.13.2 CAVAC Business Overview
8.13.3 CAVAC Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
8.13.5 CAVAC Recent Developments
8.14 Vaksindo
8.14.1 Vaksindo Comapny Information
8.14.2 Vaksindo Business Overview
8.14.3 Vaksindo Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
8.14.5 Vaksindo Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Newcastle Disease Vaccine Value Chain Analysis
9.1.1 Newcastle Disease Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Newcastle Disease Vaccine Sales Mode & Process
9.2 Newcastle Disease Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Newcastle Disease Vaccine Distributors
9.2.3 Newcastle Disease Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Newcastle Disease Vaccine Sales Value (2019-2030)
1.2.2 Global Newcastle Disease Vaccine Sales Volume (2019-2030)
1.2.3 Global Newcastle Disease Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 NEWCASTLE DISEASE VACCINE MARKET DYNAMICS
2.1 Newcastle Disease Vaccine Industry Trends
2.2 Newcastle Disease Vaccine Industry Drivers
2.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
2.4 Newcastle Disease Vaccine Industry Restraints
3 NEWCASTLE DISEASE VACCINE MARKET BY COMPANY
3.1 Global Newcastle Disease Vaccine Company Revenue Ranking in 2023
3.2 Global Newcastle Disease Vaccine Revenue by Company (2019-2024)
3.3 Global Newcastle Disease Vaccine Sales Volume by Company (2019-2024)
3.4 Global Newcastle Disease Vaccine Average Price by Company (2019-2024)
3.5 Global Newcastle Disease Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Newcastle Disease Vaccine Company Manufacturing Base & Headquarters
3.7 Global Newcastle Disease Vaccine Company, Product Type & Application
3.8 Global Newcastle Disease Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Newcastle Disease Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Newcastle Disease Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 NEWCASTLE DISEASE VACCINE MARKET BY TYPE
4.1 Newcastle Disease Vaccine Type Introduction
4.1.1 Live Vaccines
4.1.2 Killed Vaccines
4.2 Global Newcastle Disease Vaccine Sales Volume by Type
4.2.1 Global Newcastle Disease Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Newcastle Disease Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Newcastle Disease Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Newcastle Disease Vaccine Sales Value by Type
4.3.1 Global Newcastle Disease Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Newcastle Disease Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Newcastle Disease Vaccine Sales Value Share by Type (2019-2030)
5 NEWCASTLE DISEASE VACCINE MARKET BY APPLICATION
5.1 Newcastle Disease Vaccine Application Introduction
5.1.1 Chicken
5.1.2 Duck & Goose
5.1.3 Other
5.2 Global Newcastle Disease Vaccine Sales Volume by Application
5.2.1 Global Newcastle Disease Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Newcastle Disease Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Newcastle Disease Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Newcastle Disease Vaccine Sales Value by Application
5.3.1 Global Newcastle Disease Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Newcastle Disease Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Newcastle Disease Vaccine Sales Value Share by Application (2019-2030)
6 NEWCASTLE DISEASE VACCINE MARKET BY REGION
6.1 Global Newcastle Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Newcastle Disease Vaccine Sales by Region (2019-2030)
6.2.1 Global Newcastle Disease Vaccine Sales by Region: 2019-2024
6.2.2 Global Newcastle Disease Vaccine Sales by Region (2025-2030)
6.3 Global Newcastle Disease Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Newcastle Disease Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Newcastle Disease Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Newcastle Disease Vaccine Sales Value by Region (2025-2030)
6.5 Global Newcastle Disease Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Newcastle Disease Vaccine Sales Value (2019-2030)
6.6.2 North America Newcastle Disease Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Newcastle Disease Vaccine Sales Value (2019-2030)
6.7.2 Europe Newcastle Disease Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Newcastle Disease Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Newcastle Disease Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Newcastle Disease Vaccine Sales Value (2019-2030)
6.9.2 Latin America Newcastle Disease Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Newcastle Disease Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Newcastle Disease Vaccine Sales Value Share by Country, 2023 VS 2030
7 NEWCASTLE DISEASE VACCINE MARKET BY COUNTRY
7.1 Global Newcastle Disease Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Newcastle Disease Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Newcastle Disease Vaccine Sales by Country (2019-2030)
7.3.1 Global Newcastle Disease Vaccine Sales by Country (2019-2024)
7.3.2 Global Newcastle Disease Vaccine Sales by Country (2025-2030)
7.4 Global Newcastle Disease Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Newcastle Disease Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Newcastle Disease Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Merial
8.1.1 Merial Comapny Information
8.1.2 Merial Business Overview
8.1.3 Merial Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Merial Newcastle Disease Vaccine Product Portfolio
8.1.5 Merial Recent Developments
8.2 CEVA
8.2.1 CEVA Comapny Information
8.2.2 CEVA Business Overview
8.2.3 CEVA Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
8.2.5 CEVA Recent Developments
8.3 QYH Biotech
8.3.1 QYH Biotech Comapny Information
8.3.2 QYH Biotech Business Overview
8.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
8.3.5 QYH Biotech Recent Developments
8.4 Ringpu Biology
8.4.1 Ringpu Biology Comapny Information
8.4.2 Ringpu Biology Business Overview
8.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
8.4.5 Ringpu Biology Recent Developments
8.5 Yebio
8.5.1 Yebio Comapny Information
8.5.2 Yebio Business Overview
8.5.3 Yebio Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
8.5.5 Yebio Recent Developments
8.6 Harbin Veterinary Research Institute
8.6.1 Harbin Veterinary Research Institute Comapny Information
8.6.2 Harbin Veterinary Research Institute Business Overview
8.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
8.6.5 Harbin Veterinary Research Institute Recent Developments
8.7 Merck Animal Health
8.7.1 Merck Animal Health Comapny Information
8.7.2 Merck Animal Health Business Overview
8.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
8.7.5 Merck Animal Health Recent Developments
8.8 DHN
8.8.1 DHN Comapny Information
8.8.2 DHN Business Overview
8.8.3 DHN Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.8.4 DHN Newcastle Disease Vaccine Product Portfolio
8.8.5 DHN Recent Developments
8.9 Zoetis
8.9.1 Zoetis Comapny Information
8.9.2 Zoetis Business Overview
8.9.3 Zoetis Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
8.9.5 Zoetis Recent Developments
8.10 ChengDu Tecbond
8.10.1 ChengDu Tecbond Comapny Information
8.10.2 ChengDu Tecbond Business Overview
8.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
8.10.5 ChengDu Tecbond Recent Developments
8.11 Elanco (Lohmann)
8.11.1 Elanco (Lohmann) Comapny Information
8.11.2 Elanco (Lohmann) Business Overview
8.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
8.11.5 Elanco (Lohmann) Recent Developments
8.12 FATRO
8.12.1 FATRO Comapny Information
8.12.2 FATRO Business Overview
8.12.3 FATRO Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
8.12.5 FATRO Recent Developments
8.13 CAVAC
8.13.1 CAVAC Comapny Information
8.13.2 CAVAC Business Overview
8.13.3 CAVAC Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
8.13.5 CAVAC Recent Developments
8.14 Vaksindo
8.14.1 Vaksindo Comapny Information
8.14.2 Vaksindo Business Overview
8.14.3 Vaksindo Newcastle Disease Vaccine Sales, Value and Gross Margin (2019-2024)
8.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
8.14.5 Vaksindo Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Newcastle Disease Vaccine Value Chain Analysis
9.1.1 Newcastle Disease Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Newcastle Disease Vaccine Sales Mode & Process
9.2 Newcastle Disease Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Newcastle Disease Vaccine Distributors
9.2.3 Newcastle Disease Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
LIST OF TABLES
Table 1. Newcastle Disease Vaccine Industry Trends
Table 2. Newcastle Disease Vaccine Industry Drivers
Table 3. Newcastle Disease Vaccine Industry Opportunities and Challenges
Table 4. Newcastle Disease Vaccine Industry Restraints
Table 5. Global Newcastle Disease Vaccine Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Newcastle Disease Vaccine Revenue Share by Company (2019-2024)
Table 7. Global Newcastle Disease Vaccine Sales Volume by Company (M Doses) & (2019-2024)
Table 8. Global Newcastle Disease Vaccine Sales Volume Share by Company (2019-2024)
Table 9. Global Newcastle Disease Vaccine Average Price (USD/K Doses) of Company (2019-2024)
Table 10. Global Newcastle Disease Vaccine Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Newcastle Disease Vaccine Key Company Manufacturing Base & Headquarters
Table 12. Global Newcastle Disease Vaccine Company, Product Type & Application
Table 13. Global Newcastle Disease Vaccine Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Live Vaccines
Table 18. Major Companies of Killed Vaccines
Table 19. Global Newcastle Disease Vaccine Sales Volume by Type 2019 VS 2023 VS 2030 (M Doses)
Table 20. Global Newcastle Disease Vaccine Sales Volume by Type (2019-2024) & (M Doses)
Table 21. Global Newcastle Disease Vaccine Sales Volume by Type (2025-2030) & (M Doses)
Table 22. Global Newcastle Disease Vaccine Sales Volume Share by Type (2019-2024)
Table 23. Global Newcastle Disease Vaccine Sales Volume Share by Type (2025-2030)
Table 24. Global Newcastle Disease Vaccine Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Newcastle Disease Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 26. Global Newcastle Disease Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 27. Global Newcastle Disease Vaccine Sales Value Share by Type (2019-2024)
Table 28. Global Newcastle Disease Vaccine Sales Value Share by Type (2025-2030)
Table 29. Major Companies of Chicken
Table 30. Major Companies of Duck & Goose
Table 31. Major Companies of Other
Table 32. Global Newcastle Disease Vaccine Sales Volume by Application 2019 VS 2023 VS 2030 (M Doses)
Table 33. Global Newcastle Disease Vaccine Sales Volume by Application (2019-2024) & (M Doses)
Table 34. Global Newcastle Disease Vaccine Sales Volume by Application (2025-2030) & (M Doses)
Table 35. Global Newcastle Disease Vaccine Sales Volume Share by Application (2019-2024)
Table 36. Global Newcastle Disease Vaccine Sales Volume Share by Application (2025-2030)
Table 37. Global Newcastle Disease Vaccine Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global Newcastle Disease Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 39. Global Newcastle Disease Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 40. Global Newcastle Disease Vaccine Sales Value Share by Application (2019-2024)
Table 41. Global Newcastle Disease Vaccine Sales Value Share by Application (2025-2030)
Table 42. Global Newcastle Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 43. Global Newcastle Disease Vaccine Sales by Region (2019-2024) & (M Doses)
Table 44. Global Newcastle Disease Vaccine Sales Market Share by Region (2019-2024)
Table 45. Global Newcastle Disease Vaccine Sales by Region (2025-2030) & (M Doses)
Table 46. Global Newcastle Disease Vaccine Sales Market Share by Region (2025-2030)
Table 47. Global Newcastle Disease Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global Newcastle Disease Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 49. Global Newcastle Disease Vaccine Sales Value Share by Region (2019-2024)
Table 50. Global Newcastle Disease Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 51. Global Newcastle Disease Vaccine Sales Value Share by Region (2025-2030)
Table 52. Global Newcastle Disease Vaccine Market Average Price (USD/K Doses) by Region (2019-2024)
Table 53. Global Newcastle Disease Vaccine Market Average Price (USD/K Doses) by Region (2025-2030)
Table 54. Global Newcastle Disease Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 55. Global Newcastle Disease Vaccine Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. Global Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 57. Global Newcastle Disease Vaccine Sales Market Share by Country (2019-2024)
Table 58. Global Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 59. Global Newcastle Disease Vaccine Sales Market Share by Country (2025-2030)
Table 60. Global Newcastle Disease Vaccine Sales Value by Country (2019-2024) & (US$ Million)
Table 61. Global Newcastle Disease Vaccine Sales Value Market Share by Country (2019-2024)
Table 62. Global Newcastle Disease Vaccine Sales Value by Country (2025-2030) & (US$ Million)
Table 63. Global Newcastle Disease Vaccine Sales Value Market Share by Country (2025-2030)
Table 64. Merial Company Information
Table 65. Merial Business Overview
Table 66. Merial Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 67. Merial Newcastle Disease Vaccine Product Portfolio
Table 68. Merial Recent Development
Table 69. CEVA Company Information
Table 70. CEVA Business Overview
Table 71. CEVA Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 72. CEVA Newcastle Disease Vaccine Product Portfolio
Table 73. CEVA Recent Development
Table 74. QYH Biotech Company Information
Table 75. QYH Biotech Business Overview
Table 76. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 77. QYH Biotech Newcastle Disease Vaccine Product Portfolio
Table 78. QYH Biotech Recent Development
Table 79. Ringpu Biology Company Information
Table 80. Ringpu Biology Business Overview
Table 81. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 82. Ringpu Biology Newcastle Disease Vaccine Product Portfolio
Table 83. Ringpu Biology Recent Development
Table 84. Yebio Company Information
Table 85. Yebio Business Overview
Table 86. Yebio Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 87. Yebio Newcastle Disease Vaccine Product Portfolio
Table 88. Yebio Recent Development
Table 89. Harbin Veterinary Research Institute Company Information
Table 90. Harbin Veterinary Research Institute Business Overview
Table 91. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 92. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
Table 93. Harbin Veterinary Research Institute Recent Development
Table 94. Merck Animal Health Company Information
Table 95. Merck Animal Health Business Overview
Table 96. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 97. Merck Animal Health Newcastle Disease Vaccine Product Portfolio
Table 98. Merck Animal Health Recent Development
Table 99. DHN Company Information
Table 100. DHN Business Overview
Table 101. DHN Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 102. DHN Newcastle Disease Vaccine Product Portfolio
Table 103. DHN Recent Development
Table 104. Zoetis Company Information
Table 105. Zoetis Business Overview
Table 106. Zoetis Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 107. Zoetis Newcastle Disease Vaccine Product Portfolio
Table 108. Zoetis Recent Development
Table 109. ChengDu Tecbond Company Information
Table 110. ChengDu Tecbond Business Overview
Table 111. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 112. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
Table 113. ChengDu Tecbond Recent Development
Table 114. Elanco (Lohmann) Company Information
Table 115. Elanco (Lohmann) Business Overview
Table 116. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 117. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
Table 118. Elanco (Lohmann) Recent Development
Table 119. FATRO Company Information
Table 120. FATRO Business Overview
Table 121. FATRO Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 122. FATRO Newcastle Disease Vaccine Product Portfolio
Table 123. FATRO Recent Development
Table 124. CAVAC Company Information
Table 125. CAVAC Business Overview
Table 126. CAVAC Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 127. CAVAC Newcastle Disease Vaccine Product Portfolio
Table 128. CAVAC Recent Development
Table 129. Vaksindo Company Information
Table 130. Vaksindo Business Overview
Table 131. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 132. Vaksindo Newcastle Disease Vaccine Product Portfolio
Table 133. Vaksindo Recent Development
Table 134. Key Raw Materials
Table 135. Raw Materials Key Suppliers
Table 136. Newcastle Disease Vaccine Distributors List
Table 137. Newcastle Disease Vaccine Customers List
Table 138. Research Programs/Design for This Report
Table 139. Authors List of This Report
Table 140. Secondary Sources
Table 141. Primary Sources
Table 1. Newcastle Disease Vaccine Industry Trends
Table 2. Newcastle Disease Vaccine Industry Drivers
Table 3. Newcastle Disease Vaccine Industry Opportunities and Challenges
Table 4. Newcastle Disease Vaccine Industry Restraints
Table 5. Global Newcastle Disease Vaccine Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Newcastle Disease Vaccine Revenue Share by Company (2019-2024)
Table 7. Global Newcastle Disease Vaccine Sales Volume by Company (M Doses) & (2019-2024)
Table 8. Global Newcastle Disease Vaccine Sales Volume Share by Company (2019-2024)
Table 9. Global Newcastle Disease Vaccine Average Price (USD/K Doses) of Company (2019-2024)
Table 10. Global Newcastle Disease Vaccine Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Newcastle Disease Vaccine Key Company Manufacturing Base & Headquarters
Table 12. Global Newcastle Disease Vaccine Company, Product Type & Application
Table 13. Global Newcastle Disease Vaccine Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Newcastle Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Live Vaccines
Table 18. Major Companies of Killed Vaccines
Table 19. Global Newcastle Disease Vaccine Sales Volume by Type 2019 VS 2023 VS 2030 (M Doses)
Table 20. Global Newcastle Disease Vaccine Sales Volume by Type (2019-2024) & (M Doses)
Table 21. Global Newcastle Disease Vaccine Sales Volume by Type (2025-2030) & (M Doses)
Table 22. Global Newcastle Disease Vaccine Sales Volume Share by Type (2019-2024)
Table 23. Global Newcastle Disease Vaccine Sales Volume Share by Type (2025-2030)
Table 24. Global Newcastle Disease Vaccine Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Newcastle Disease Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 26. Global Newcastle Disease Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 27. Global Newcastle Disease Vaccine Sales Value Share by Type (2019-2024)
Table 28. Global Newcastle Disease Vaccine Sales Value Share by Type (2025-2030)
Table 29. Major Companies of Chicken
Table 30. Major Companies of Duck & Goose
Table 31. Major Companies of Other
Table 32. Global Newcastle Disease Vaccine Sales Volume by Application 2019 VS 2023 VS 2030 (M Doses)
Table 33. Global Newcastle Disease Vaccine Sales Volume by Application (2019-2024) & (M Doses)
Table 34. Global Newcastle Disease Vaccine Sales Volume by Application (2025-2030) & (M Doses)
Table 35. Global Newcastle Disease Vaccine Sales Volume Share by Application (2019-2024)
Table 36. Global Newcastle Disease Vaccine Sales Volume Share by Application (2025-2030)
Table 37. Global Newcastle Disease Vaccine Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global Newcastle Disease Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 39. Global Newcastle Disease Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 40. Global Newcastle Disease Vaccine Sales Value Share by Application (2019-2024)
Table 41. Global Newcastle Disease Vaccine Sales Value Share by Application (2025-2030)
Table 42. Global Newcastle Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 43. Global Newcastle Disease Vaccine Sales by Region (2019-2024) & (M Doses)
Table 44. Global Newcastle Disease Vaccine Sales Market Share by Region (2019-2024)
Table 45. Global Newcastle Disease Vaccine Sales by Region (2025-2030) & (M Doses)
Table 46. Global Newcastle Disease Vaccine Sales Market Share by Region (2025-2030)
Table 47. Global Newcastle Disease Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global Newcastle Disease Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 49. Global Newcastle Disease Vaccine Sales Value Share by Region (2019-2024)
Table 50. Global Newcastle Disease Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 51. Global Newcastle Disease Vaccine Sales Value Share by Region (2025-2030)
Table 52. Global Newcastle Disease Vaccine Market Average Price (USD/K Doses) by Region (2019-2024)
Table 53. Global Newcastle Disease Vaccine Market Average Price (USD/K Doses) by Region (2025-2030)
Table 54. Global Newcastle Disease Vaccine Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Table 55. Global Newcastle Disease Vaccine Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. Global Newcastle Disease Vaccine Sales by Country (2019-2024) & (M Doses)
Table 57. Global Newcastle Disease Vaccine Sales Market Share by Country (2019-2024)
Table 58. Global Newcastle Disease Vaccine Sales by Country (2025-2030) & (M Doses)
Table 59. Global Newcastle Disease Vaccine Sales Market Share by Country (2025-2030)
Table 60. Global Newcastle Disease Vaccine Sales Value by Country (2019-2024) & (US$ Million)
Table 61. Global Newcastle Disease Vaccine Sales Value Market Share by Country (2019-2024)
Table 62. Global Newcastle Disease Vaccine Sales Value by Country (2025-2030) & (US$ Million)
Table 63. Global Newcastle Disease Vaccine Sales Value Market Share by Country (2025-2030)
Table 64. Merial Company Information
Table 65. Merial Business Overview
Table 66. Merial Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 67. Merial Newcastle Disease Vaccine Product Portfolio
Table 68. Merial Recent Development
Table 69. CEVA Company Information
Table 70. CEVA Business Overview
Table 71. CEVA Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 72. CEVA Newcastle Disease Vaccine Product Portfolio
Table 73. CEVA Recent Development
Table 74. QYH Biotech Company Information
Table 75. QYH Biotech Business Overview
Table 76. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 77. QYH Biotech Newcastle Disease Vaccine Product Portfolio
Table 78. QYH Biotech Recent Development
Table 79. Ringpu Biology Company Information
Table 80. Ringpu Biology Business Overview
Table 81. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 82. Ringpu Biology Newcastle Disease Vaccine Product Portfolio
Table 83. Ringpu Biology Recent Development
Table 84. Yebio Company Information
Table 85. Yebio Business Overview
Table 86. Yebio Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 87. Yebio Newcastle Disease Vaccine Product Portfolio
Table 88. Yebio Recent Development
Table 89. Harbin Veterinary Research Institute Company Information
Table 90. Harbin Veterinary Research Institute Business Overview
Table 91. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 92. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
Table 93. Harbin Veterinary Research Institute Recent Development
Table 94. Merck Animal Health Company Information
Table 95. Merck Animal Health Business Overview
Table 96. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 97. Merck Animal Health Newcastle Disease Vaccine Product Portfolio
Table 98. Merck Animal Health Recent Development
Table 99. DHN Company Information
Table 100. DHN Business Overview
Table 101. DHN Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 102. DHN Newcastle Disease Vaccine Product Portfolio
Table 103. DHN Recent Development
Table 104. Zoetis Company Information
Table 105. Zoetis Business Overview
Table 106. Zoetis Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 107. Zoetis Newcastle Disease Vaccine Product Portfolio
Table 108. Zoetis Recent Development
Table 109. ChengDu Tecbond Company Information
Table 110. ChengDu Tecbond Business Overview
Table 111. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 112. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
Table 113. ChengDu Tecbond Recent Development
Table 114. Elanco (Lohmann) Company Information
Table 115. Elanco (Lohmann) Business Overview
Table 116. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 117. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
Table 118. Elanco (Lohmann) Recent Development
Table 119. FATRO Company Information
Table 120. FATRO Business Overview
Table 121. FATRO Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 122. FATRO Newcastle Disease Vaccine Product Portfolio
Table 123. FATRO Recent Development
Table 124. CAVAC Company Information
Table 125. CAVAC Business Overview
Table 126. CAVAC Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 127. CAVAC Newcastle Disease Vaccine Product Portfolio
Table 128. CAVAC Recent Development
Table 129. Vaksindo Company Information
Table 130. Vaksindo Business Overview
Table 131. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 132. Vaksindo Newcastle Disease Vaccine Product Portfolio
Table 133. Vaksindo Recent Development
Table 134. Key Raw Materials
Table 135. Raw Materials Key Suppliers
Table 136. Newcastle Disease Vaccine Distributors List
Table 137. Newcastle Disease Vaccine Customers List
Table 138. Research Programs/Design for This Report
Table 139. Authors List of This Report
Table 140. Secondary Sources
Table 141. Primary Sources
LIST OF FIGURES
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease Vaccine Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Newcastle Disease Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Newcastle Disease Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Newcastle Disease Vaccine Sales Average Price (USD/K Doses) & (2019-2030)
Figure 6. Global Newcastle Disease Vaccine Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Live Vaccines Picture
Figure 10. Killed Vaccines Picture
Figure 11. Global Newcastle Disease Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 12. Global Newcastle Disease Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 13. Global Newcastle Disease Vaccine Sales Volume Share by Type (2019-2030)
Figure 14. Global Newcastle Disease Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Newcastle Disease Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 16. Global Newcastle Disease Vaccine Sales Value Share by Type (2019-2030)
Figure 17. Chicken Picture
Figure 18. Duck & Goose Picture
Figure 19. Other Picture
Figure 20. Global Newcastle Disease Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 21. Global Newcastle Disease Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 22. Global Newcastle Disease Vaccine Sales Volume Share by Application (2019-2030)
Figure 23. Global Newcastle Disease Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Newcastle Disease Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 25. Global Newcastle Disease Vaccine Sales Value Share by Application (2019-2030)
Figure 26. Global Newcastle Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 27. Global Newcastle Disease Vaccine Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. Global Newcastle Disease Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 29. Global Newcastle Disease Vaccine Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Newcastle Disease Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Newcastle Disease Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 32. Europe Newcastle Disease Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Newcastle Disease Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 34. Asia-Pacific Newcastle Disease Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Newcastle Disease Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 36. Latin America Newcastle Disease Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 37. Latin America Newcastle Disease Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Newcastle Disease Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Newcastle Disease Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 40. USA Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 41. USA Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 42. USA Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 43. Canada Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. Canada Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. Canada Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Germany Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Germany Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Germany Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. France Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. France Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. France Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. U.K. Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.K. Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. U.K. Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. Italy Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. Italy Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. Italy Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Netherlands Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Netherlands Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 203
Figure 1. Newcastle Disease Vaccine Product Picture
Figure 2. Global Newcastle Disease Vaccine Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Newcastle Disease Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Newcastle Disease Vaccine Sales (2019-2030) & (M Doses)
Figure 5. Global Newcastle Disease Vaccine Sales Average Price (USD/K Doses) & (2019-2030)
Figure 6. Global Newcastle Disease Vaccine Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Live Vaccines Picture
Figure 10. Killed Vaccines Picture
Figure 11. Global Newcastle Disease Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 12. Global Newcastle Disease Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 13. Global Newcastle Disease Vaccine Sales Volume Share by Type (2019-2030)
Figure 14. Global Newcastle Disease Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Newcastle Disease Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 16. Global Newcastle Disease Vaccine Sales Value Share by Type (2019-2030)
Figure 17. Chicken Picture
Figure 18. Duck & Goose Picture
Figure 19. Other Picture
Figure 20. Global Newcastle Disease Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 21. Global Newcastle Disease Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 22. Global Newcastle Disease Vaccine Sales Volume Share by Application (2019-2030)
Figure 23. Global Newcastle Disease Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Newcastle Disease Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 25. Global Newcastle Disease Vaccine Sales Value Share by Application (2019-2030)
Figure 26. Global Newcastle Disease Vaccine Sales by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 27. Global Newcastle Disease Vaccine Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. Global Newcastle Disease Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 29. Global Newcastle Disease Vaccine Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Newcastle Disease Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Newcastle Disease Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 32. Europe Newcastle Disease Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Newcastle Disease Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 34. Asia-Pacific Newcastle Disease Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Newcastle Disease Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 36. Latin America Newcastle Disease Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 37. Latin America Newcastle Disease Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Newcastle Disease Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Newcastle Disease Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 40. USA Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 41. USA Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 42. USA Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 43. Canada Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. Canada Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. Canada Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Germany Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Germany Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Germany Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. France Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. France Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. France Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. U.K. Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.K. Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. U.K. Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. Italy Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. Italy Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. Italy Newcastle Disease Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Netherlands Newcastle Disease Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Netherlands Newcastle Disease Vaccine Sales Value Share by Type, 2023 VS 203
